Ramaroson Andriantsitohaina Selected Research

delphinidin

12/2021	Enhancement of the Anti-Angiogenic Effects of Delphinidin When Encapsulated within Small Extracellular Vesicles.
1/2017	Estrogen receptor α/HDAC/NFAT axis for delphinidin effects on proliferation and differentiation of T lymphocytes from patients with cardiovascular risks.
1/2015	Delphinidin Inhibits Tumor Growth by Acting on VEGF Signalling in Endothelial Cells.
8/2014	Delphinidin inhibits VEGF induced-mitochondrial biogenesis and Akt activation in endothelial cells.
12/2013	Pleiotropic beneficial effects of epigallocatechin gallate, quercetin and delphinidin on cardiovascular diseases associated with endothelial dysfunction.
4/2011	Anticancer properties of flavonoids: roles in various stages of carcinogenesis.
7/2003	Delphinidin, an active compound of red wine, inhibits endothelial cell apoptosis via nitric oxide pathway and regulation of calcium homeostasis.
2/2003	Delphinidin inhibits endothelial cell proliferation and cell cycle progression through a transient activation of ERK-1/-2.
3/2002	Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ramaroson Andriantsitohaina Research Topics

Disease

16	Inflammation (Inflammations) 01/2021 - 01/2005
14	Hypertension (High Blood Pressure) 01/2019 - 03/2002
13	Neoplasms (Cancer) 12/2021 - 02/2003
11	Obesity 10/2021 - 01/2009
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 04/2002
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2011
9	Atherosclerosis 11/2020 - 04/2002
6	Body Weight (Weight, Body) 01/2022 - 12/2014
6	Insulin Resistance 01/2022 - 12/2014
5	Ischemia 01/2020 - 03/2008
5	Fibrosis (Cirrhosis) 11/2015 - 03/2002
5	Septic Shock (Toxic Shock Syndrome) 10/2015 - 01/2009
4	Infarction (Infarctions) 01/2020 - 06/2004
4	Myocardial Infarction 01/2020 - 04/2002
4	Carcinogenesis 01/2018 - 03/2011
4	Sepsis (Septicemia) 07/2013 - 12/2007
4	Stroke (Strokes) 11/2012 - 01/2005
3	Endotoxemia 01/2021 - 07/2009
3	Necrosis 01/2019 - 07/2003
3	Obstructive Sleep Apnea 01/2018 - 10/2012
3	Hypoxia (Hypoxemia) 01/2018 - 10/2008
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2018
2	Heart Failure 01/2017 - 09/2007
2	Shock 01/2016 - 01/2009
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2015 - 03/2002
2	Vascular Remodeling 08/2004 - 03/2002
2	Reperfusion Injury 06/2004 - 04/2002
1	Weight Loss (Weight Reduction) 01/2023
1	Morbid Obesity 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Breast Neoplasms (Breast Cancer) 09/2022
1	Infertility (Sterility) 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Dysbiosis 01/2021
1	Pathologic Constriction (Stenosis) 01/2020

Drug/Important Bio-Agent (IBA)

20	PolyphenolsIBA 01/2020 - 03/2002
14	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2022 - 03/2002
9	delphinidinIBA 12/2021 - 03/2002
9	Nitric Oxide Synthase (NO Synthase)IBA 07/2013 - 03/2002
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2014
5	LipopolysaccharidesIBA 01/2023 - 01/2009
5	NG-Nitroarginine Methyl Ester (L-NAME)IBA 12/2009 - 03/2002
4	Insulin (Novolin)FDA Link 11/2020 - 08/2011
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2008
4	Myosin-Light-Chain KinaseIBA 01/2018 - 10/2015
4	FlavonoidsIBA 12/2013 - 10/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 12/2014
3	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2011
3	PhytochemicalsIBA 12/2013 - 11/2009
3	Oxygen (Dioxygen)IBA 10/2012 - 10/2008
3	Superoxides (Superoxide)IBA 01/2012 - 01/2009
3	EnzymesIBA 07/2011 - 01/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2011 - 02/2003
3	Protein CIBA 01/2011 - 01/2009
3	Adenosine Triphosphate (ATP)IBA 12/2009 - 07/2003
3	Adenosine Triphosphatases (ATPase)IBA 12/2009 - 07/2003
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2021 - 01/2021
2	ApolipoproteinsIBA 11/2020 - 11/2017
2	LipidsIBA 01/2020 - 12/2014
2	LigandsIBA 01/2020 - 01/2015
2	Ethanol (Ethyl Alcohol)IBA 01/2019 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 10/2017
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 06/2009
2	LeptinIBA 01/2019 - 01/2019
2	Angiotensin IIIBA 01/2019 - 01/2013
2	Chlordecone (Kepone)IBA 01/2018 - 12/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 08/2014
2	QuercetinIBA 12/2013 - 10/2006
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2013 - 04/2011
2	AntioxidantsIBA 12/2013 - 01/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2013 - 01/2009
2	Hexachlorocyclohexane (gamma-Hexachlorocyclohexane)FDA LinkGeneric 10/2013 - 12/2012
2	Human Serum Albumin FDA LinkGeneric 06/2011 - 12/2007
2	Vasoconstrictor AgentsIBA 07/2007 - 03/2003
2	PPAR alphaIBA 07/2006 - 04/2002
2	ProstaglandinsIBA 03/2003 - 02/2003
1	Leptin ReceptorsIBA 01/2023
1	matrigelIBA 09/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	AMP-Activated Protein KinasesIBA 10/2021
1	Steroidogenic Factor 1IBA 10/2021
1	VLDL LipoproteinsIBA 04/2021
1	PropionatesIBA 04/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	oxidized low density lipoproteinIBA 11/2020
1	Carotenoids (Carotene)IBA 01/2020
1	Fatty Acid-Binding ProteinsIBA 01/2020
1	Troponin IIBA 01/2020
1	Guanosine Triphosphate (GTP)IBA 01/2020
1	erucylphosphocholineIBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019

Therapy/Procedure

3	Therapeutics 10/2021 - 01/2017
3	Oral Administration 01/2019 - 06/2004
1	Intravenous Injections 10/2021
1	Precision Medicine 01/2020